baylor-logo-wire-500x500.jpg
Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024
March 04, 2024 10:00 ET | Baylor Genetics
Researchers present abstracts and poster sessions showcasing research and clinical solutions. Joint session planned with Illumina.
MnM_logo_TM_JPG.JPG
Carrier Screening Market is Expected to Reach $5.4 Billion | MarketsandMarkets™
February 15, 2024 07:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Carrier Screening market in terms of revenue was estimated to be worth $2.2 billion in 2023 and is poised to reach $5.4 billion by 2028, growing at a CAGR...
Asia-Pacific Rare Disease Genetic Testing Market
Asia-Pacific Rare Disease Genetic Testing Market Report 2023-2033: AI-based Diagnostic Tools Presenting Lucrative Opportunities for Market Players
January 30, 2024 09:32 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Rare Disease Genetic Testing Market - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The...
Asia-Pacific Multicancer Screening Market
Asia-Pacific Multicancer Screening Market Analysis and Forecast, 2023-2032, Featuring Burning Rock DX, Genecast Biotechnology Co, and Konica Minolta (Ambry Genetics)
January 29, 2024 11:50 ET | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Multicancer Screening Market - Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.As of 2022,...
website-logo (2).png
Epigenetics Market Predicted to Garner USD 12.7 Billion By 2033, At CAGR 19.2% | Exclusive Report by Marketresearch.biz
January 16, 2024 03:58 ET | MarketResearch.biz
New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The epigenetics market was valued at USD 2.3 billion in 2023 with a significant growth and is projected to reach at USD 12.7 billion by 2033 with a CAGR...
Global DNA/RNA Sample Extraction and Isolation Market
DNA/RNA Sample Extraction & Isolation Industry, Forecast to 2033: High-Quality Spin Columns & Membranes are the Future of Nucleic Acid Isolation
January 10, 2024 09:13 ET | Research and Markets
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The "DNA/RNA Sample Extraction and Isolation Market - A Global and Regional Analysis: Focus on Product, Technology, Application, End User, and Region -...
baylor-logo-wire-500x500.jpg
Baylor Genetics Accelerates Growth, Combines Clinical and Scientific Expertise with Commercial Capabilities to Meet Increased Needs of Patients, Providers and Partners
January 03, 2024 10:00 ET | Baylor Genetics
Company Expands Test Offerings, Lab Technology, and Customer-Centric Tools Rapid Comprehensive Whole Genome and Exome Sequencing, Disease-Specific Panels and Customizable Solutions Advance Diagnoses...
Photo Collage (Optimi)
Optimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability Testing
November 28, 2023 07:42 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health...
Emergen logo.png
Global Genetic Testing Market Size to Reach USD 34.40 Billion in 2032 | Emergen Research
November 13, 2023 12:30 ET | Emergen Research
Vancouver, Nov. 13, 2023 (GLOBE NEWSWIRE) -- The global genetic testing market size was USD 13.01 Billion in 2022 and is expected to register a rapid revenue CAGR of 10.2% during the forecast...
NeuroQure Logo.png
Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
November 06, 2023 12:00 ET | NeuroQure
IRVINE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- NeuroQure has embarked on a transformative journey aimed at revolutionizing the treatment landscape for Fragile X Syndrome and Autism Spectrum...